Global Markets for Orphan Drugs to reach $112.1 billion by 2017

The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. Extensive research in this field has resulted in biological and nonbiological therapeutic treatments for a number of rare diseases. Technological advances, new product launches, and increasing assistance from regulatory bodies will spur steady growth in this market for foreseeable future.

BCC Research provides an in-depth analysis of the global orphan drugs market through its report Global Markets for Orphan Drugs. According to the report, this market was valued at $86.1 billion in 2012. BCC Research projects the market to grow to $112.1 billion by 2017, and register a five-year compound annual growth rate (CAGR) of 5.4% from 2012 to 2017.

 RSS Feeds – Pharmaceuticals

Use this report to:

• Gain an overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, and future growth trends.
• Analyze global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
• Evaluate specific rare diseases for which orphan drugs exist.
• Assess the most promising therapeutic areas in the market.
• Examine an outline of legislation and regulation, including public and private agencies involved in support and development.
• Review comprehensive company profiles of major players in the industry.

To order your copy of this report or to download the complimentary introduction chapter click here.

Global Molecular, Atomic and Nanoscale Imaging Market to Reach Nearly $4.4 Billion in 2017

The global molecular, atomic and nanoscale imaging market is expected to grow from nearly $3.1 billion in 2011 to $4.4 billion by 2017 at a compound annual growth rate (CAGR) of 6.8% from 2012 to 2017. The increasing aging population and life expectancy, the increasing incidence of chronic diseases, and technological advancements are driving the medical imaging market.

Electron and ion microscopy had the largest market share (49%) in 2011. Imaging probes (fluorescent and bioluminescent probes and nanoparticles and quantum dots) had the smallest market with an approximately 11% share in the same year in the molecular, atomic, and nanoscale imaging market.
Lack of regulations and liberalization of many of the countries in the Asia-Pacific region have opened up prospective opportunities for microscopes in several end-user industries.

 RSS Feeds – Advanced materials

The demand of effective microscopy techniques is increasing in these regions due to the progressive shift of manufacturing facilities in the semiconductor manufacturing and electronics industries. Additionally, the greater emphasis on quality levels in industrial and biological research activities has augmented the demand for effective and advanced microscopy techniques.

The electron microscopes market is bigger than that of ion microscopes. A wide range of applications of electron microscopes is the driving factor for this market. Product innovations and increasing applications are also driving the market for electron microscopes.

The fluorescent and bioluminescent probes market is larger than the nanoparticles and quantum dots markets. Commercially available quantum dots are promising competitors of fluorescent and bioluminescent probes. Therefore, the market for quantum dots is increasing at a higher growth rate than the fluorescent and bioluminescent probes market. The optical and thermal market is growing and is experiencing an oligopoly market structure. Pharmaceutical companies and academic research labs are the major end users of optical imaging systems. Due to their relatively low cost, optical imaging systems are preferred over the other kinds of microscopes.

BCC Research’s goal in conducting this study, GLOBAL MARKETS AND TECHNOLOGIES FOR MOLECULAR NANOSCALE AND ATOMIC IMAGING (NAN046B) is to provide an overview of the current and future characteristics of the global markets and technologies for molecular, nanoscale, and atomic imaging. The key objective is to present the future direction and comprehensive analysis for the molecular, nanoscale, and atomic imaging technologies markets, and their positions in the overall global imaging market.

This report explores present and future strategies within the global markets and technologies for molecular, nanoscale, and atomic imaging, including the electron and ion microscope market, the imaging probes market, the scanning probes market, and the optical and thermal imaging market. The improvisation of the market, and the setbacks and needs of the market are discussed in this report. The comparisons, usage, and the advantages and disadvantages of different types of technologies related to molecular, nanoscale, and atomic imaging also are portrayed in this report.